Trend in the production of anti-leukocyte antibodies against paternal antigens during allogeneic cell immunization in women with recurrent miscarriage


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To estimate the trend in the production of anti-paternal anti-leukocyte antibodies during partner cell immunization of women with recurrent miscarriage in the pregestational preparation period and in the f irst trimester of pregnancy. Subjects and methods. Flow cytometry was used to determine anti-paternal antibodies (anti-PAbs) in 53 women with recurrent miscarriage, 20 fertile nonpregnant women, and 7 women with physiological primipregnancy. Results. In the first trimester, no anti-PAbs were found in the control group of primigravida. There were no differences in anti-PAb levels in the women with recurrent miscarriage before treatment and in the fertile women. An immunocytotherapy procedure resulted in a gradual significant increase in anti-PAbs as compared to the baseline level. In the patients who had become pregnant, the level of anti-PAbs remained high during the first trimester. Conclusion. The findings are suggestive of the importance of the anti-PAb test as reflecting the immunomodulatory effect of allogeneic partner cell administration

作者简介

Lyubov Krechetova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: k_l_v_@mail.ru
Ph.D. in medical sciences, Head of Laboratory of Clinical Immunology

Nelly Khachatryan

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: nelly1986@mail.ru
Graduate student, Department of Pregnancy Loss Prevention and Therapy

Nana Tetruashvili

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: n_tetruashvili@oparina4.ru
Doctor of Medicine, Head of the Department of Pregnancy Loss Prevention and Therapy

Valentina Vtorushina

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: vtorushina@inbox.ru
Ph.D. in medical sciences, doctor of laboratory diagnostics in Laboratory of Clinical Immunology

Elena Stepanova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: elena2404.07@mail.ru
Junior researcher, Laboratory of Clinical Immunology

Elena Golubeva

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: e_golubeva@oparina4.ru
Ph.D. in medical sciences, doctor of laboratory diagnostics in Laboratory of Clinical Immunology

Marina Nikolaeva

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: nikolaeva_ma@mail.ru
Doctor of Science, Leading researcher, Laboratory of Clinical Immunology

Gennady Sukhikh

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: g_sukhikh@oparina4.ru
PhD, MD, professor, academician of RAS, Director

参考

  1. Nielsen H.S., Witvliet M.D., Steffensen R., Haasnoot G.W., Goulmy E., Christiansen O.B., Claas F. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J. Reprod. Immunol. 2010; 87(1-2): 67-73.
  2. Ober C., Hyslop T., Elias S., Weitkamp L.R., Hauck W.W. Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study. Hum. Reprod. 1998; 13(1): 33-8.
  3. Сидельникова В.М. Подготовка и ведение беременности у женщин с привычным невынашиванием. Методические пособия и клинические рекомендации. М.: МЕДпресс-информ; 2013. 224 с. [Sidelnikova V.M. Preparation and maintenance of pregnancy in women with recurrent pregnancy loss: manuals and clinical guidelines. M: MEDpressinform, 2011. 224 p. (in Russian)]
  4. Bartel G., Walch K., Wahrmann M., Pils S., Küssel L., Polterauer S. et al. Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: no association with unexplained recurrent miscarriage. Hum. Immunol. 2011; 72(2): 187-92.
  5. Lashley E.E., Meuleman T., Claas F.H. Beneficial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis. Am. J. Reprod. Immunol. 2013; 70(2): 87-103.
  6. Garovoy M.R., Rheinschmidt M.A., Bigos M., Perkins H., Colombe B., Feduska N., Salvatierra O. Flow cytometry analysis: a high technology crossmatch technique facilitating transplantation. Transplant. Proc. 1983; 15: 1939-44.
  7. Cook D.J., Terasaki P.I., Iwaki Y., Terashita G., Takeda A., Fujikawa J. et al. The flow cytometry crossmatch in kidney transplantation. Clin. Transplant. 1987; 409-14.
  8. Maruyama T., Makino T., Sugi T., Iwasaki K., Ozawa N., Matsubayashi H., Nozawa S. Flow cytometric crossmatch and early pregnancy loss in women with a history of recurrent spontaneous abortions who underwent paternal leukocyte immunotherapy. Am. J. Obstet. Gynecol. 1993; 168(5): 1528-36.
  9. Ormerod M.G., ed. Flow cytometry: a practical approach. 3rd ed. Oxford: Oxford University Press; 2000. 276 p.
  10. Chaouat G., Petitbarat M., Dubanchet S., Rahmati M., Ledée N.Tolerance to the foetal allograft? Am. J. Reprod. Immunol. 2010; 63(6): 624-36.
  11. Regan L., Braude P.R., Hill D.P. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum. Reprod. 1991; 6(2): 294-8.
  12. Сидельникова В.М., Сухих Г.Т. Невынашивание беременности. Руководство для практикующих врачей. М.: МИА; 2011. 516 с. [Sidelnikova V.M., Sukhikh G.T. Recurrent pregnancy loss: Guidelines for clinicians. M: Medical News Agency, 2011. 224p. (in Russian)]
  13. Gutierrez G., Gentile T., Miranda S., Margni R.A. Asymmetric antibodies: a protective arm in pregnancy. Chem. Immunol. Allergy. 2005; 89: 158-68.
  14. Mor G., Cardenas I., Abrahams V., Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann. N. Y. Acad. Sci. 2011; 1221: 80-7.
  15. Carp Howard J.A., ed. Reccurent pregnancy loss: causes, controversies and treatment. 2nd ed. CRC Press; 2014. 456 p.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##